Osteoporotic Fractures

Also known as: Osteoporosis Fracture / Osteoporotic Fracture / Osteoporosis with current pathological fracture / Osteoporotic fracture (morphologic abnormality) / Osteoporosis with fracture / Fracture due to osteoporosis / [X]Unspecified osteoporosis with pathological fracture (disorder)

DrugDrug NameDrug Description
DB00017Salmon calcitoninA synthetic peptide form of calcitonin used to inhibit bone resorption in the treatment of hypercalcemia, osteoporosis, and Paget's disease.
DrugDrug NameTargetType
DB00017Salmon calcitoninCalcitonin receptortarget
DrugDrug NamePhaseStatusCount
DB06285Teriparatide2Active Not Recruiting1
DB06285Teriparatide2Enrolling by Invitation1
DB06643Denosumab4Active Not Recruiting1
DB00884Risedronic acid4Unknown Status1
DB11866Romosozumab4Not Yet Recruiting1
DB00399Zoledronic acid4Active Not Recruiting2
DB00399Zoledronic acid4Not Yet Recruiting1
DB00399Zoledronic acid4Recruiting1
DB06643DenosumabNot AvailableCompleted1